Xenogeneic direct hemoperfusion using whole swine liver for liver failure in dogs

Journal of Surgical Research

Volumn 111, Issue 2, 2003, Pages 229-235

  Naruse, Katsutoshi ^a   Sakai, Yasuyuki ^b   Natori, Takeshi ^a   Guo, Lei ^a   Shindoh, Junichi ^a   Iida, Yuhki ^a   Michishita, Kazuya ^a   Karasawa, Yasuaki ^a   Kojima, Kentaro ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSTITUTE OF INDUSTRIAL SCIENCE   (Japan)

Author keywords

Canine liver failure model; Extracorporeal whole liver perfusion; Hybrid bioartificial liver; Xenogeneic direct hemoperfusion

Indexed keywords

AMMONIA; DISSOLVED OXYGEN; PROTEIN;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BILIARY EXCRETION; BIOARTIFICIAL ORGAN; BLOOD; BLOOD ANALYSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; DETOXIFICATION; DOG; HEMOPERFUSION; HISTOLOGY; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN ADSORBENT COLUMN; INTERMETHOD COMPARISON; JUGULAR VEIN; LEUKOCYTE ADSORBENT COLUMN; LIGAMENT; LIGATION; LIVER FAILURE; LIVER FUNCTION; NONHUMAN; OXYGENATOR; PORTOCAVAL SHUNT; PRIORITY JOURNAL; PROTEIN ANALYSIS; SWINE; TREATMENT OUTCOME; XENOGRAFT;

EID: 0037678829     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00045-3     Document Type: Article

References (14)

1. Eisemann B., Liem D. S., Raffucci F. Heterologous liver perfusion in treatment of hepatic failure. Ann. Surg. 162:1965;329.
2. Abouna G. M., Serrou B., Boehmig H. G., Amemiya H., Martineau G. Long-term hepatic support by intermittent multi-species liver perfusions. Lancet. 2:1970;391.
3. Neuhaus P., Blumhardt G. Extracorporeal liver perfusion applications of an improved model for experimental studies of the liver . Int. J. Artif. Organs. 16:1993;729.
4. Chiari R. S., Colllins B. H., Magee J. C., DiMaio J. M., Kirk A. D., Harland R. C., McCann R. L., Platt J. L., Meyer W. C. Brief report Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation . N. Eng. J. Med. 31:1994;234.
5. Schön M. R., Heil W., Lemmens H. P., Padval D., Neuhaus P., Hammer C. Xenogeneic extracorporeal liver perfusion in primates improves the ratio of branched-chain amino acids to aromatic amino acids (Fischer's ratio). Eur. Surg. Res. 31:1999;230.
6. Ozawa K., Kamiyama Y., Kimura K., Ukikusa M., Kono Y., Yamato T., Tobe T. The effects of heterologous liver cross-hemodialysis on adenylate energy charge of the remnant liver after major hepatic resection. Artif. Organs. 6:1982;447.
7. Naruse K., Sakai Y., Guo L., Shindoh J., Son J. C., Makuuchi M. Development of xenogeneic direct hemoperfusion method in a bioartificial liver system. J. Artif. Organs. 5:2002;257.
8. Naruse K., Makuuchi M. Development and perspectives of bioartificial liver support. Hepatogastroenterology. 49:2002;91.
9. Rozga J., Michael D., Holzman D., Ro M. S., Griffin D. W., Demetriou A. A. Development of a hybrid bioartificial liver. Ann. Surgery. 217:1993;502.
10. Gerlach J. Development of a hybrid liver support system A review . Int. J. Artif. Organs. 19:1996;645.
11. Naruse K., Sakai Y., Nagashima I., Jiang G. X., Suzuki M., Muto T. Development of a new bioartificial liver module filled with porcine hepatocytes immobilized on non-woven fabric. Int. J. Artif. Organs. 19:1996;347.
12. Takenaka Y. Lymphocytaheresis. Artif. Organs. 20:1996;914. Review.
13. Yamazaki Z., Fujimori Y., Takahama T., Inoue N., Wada T., Inagaki K. Efficiency and biocompatibility of a new immunosorbent. Trans. Am. Soc. Artif. Intern. Organs. 28:1982;318.
14. International Patent Application for PCT: No. PCT/JP01/02233: A new bioartificial organ system. Priority date 2000.3.22. Inventor & Applicant: Katsutoshi Naruse.